Granisetron 4mg/4ml Inj, 4ml
Overview
What is this medicine?
How to Use This Medicine
For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep this medication at home.
If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Report any unusual side effects, especially headache, constipation, or dizziness.
- Stay hydrated, especially if experiencing vomiting or diarrhea.
- Avoid driving or operating machinery if you experience dizziness or fatigue.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Chest pain or pressure
Fast or abnormal heartbeat
Shortness of breath
Stomach pain
Swelling of the belly
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Additionally, a severe and potentially life-threatening condition called serotonin syndrome may occur, especially if you are taking certain other medications. If you experience any of the following symptoms, contact your doctor immediately:
Agitation
Changes in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Vomiting
Severe headache
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Headache
Dizziness
Drowsiness
Fatigue
Weakness
Diarrhea or constipation
Heartburn
Decreased appetite
Trouble sleeping
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe headache
- Severe constipation or abdominal pain
- Dizziness or lightheadedness, especially when standing up
- Fast or irregular heartbeat (palpitations)
- Signs of an allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
- Symptoms of serotonin syndrome (agitation, confusion, hallucinations, rapid heart rate, sweating, muscle stiffness or twitching, loss of coordination, nausea, vomiting, diarrhea)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking another medication that contains the same active ingredient as this drug.
If you are taking apomorphine, as this may interact with this medication.
Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to discuss all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. This includes:
All prescription medications you are currently taking
Over-the-counter (OTC) medications
Natural products, such as herbal supplements
* Vitamins
Additionally, inform your doctor about any existing health problems. It is vital to verify that it is safe to take this medication with all of your current medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Be aware that some formulations of this medication may contain benzyl alcohol. If possible, it is recommended to avoid using products with benzyl alcohol in newborns and infants, as certain doses of benzyl alcohol can cause severe side effects in these children, particularly when combined with other medications containing benzyl alcohol. Consult your doctor to determine if this product contains benzyl alcohol.
If you are pregnant, planning to become pregnant, or are breastfeeding, notify your doctor. You and your doctor will need to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Headache
- Constipation
- Mild hypotension
- QT prolongation (rare, but possible with very high doses)
What to Do:
There is no specific antidote for granisetron overdose. Treatment should be symptomatic and supportive. Call 1-800-222-1222 (Poison Control Center) immediately for advice.
Drug Interactions
Major Interactions
- QT-prolonging agents (e.g., amiodarone, sotalol, quinidine, procainamide, disopyramide, dofetilide, cisapride, pimozide, thioridazine, ziprasidone, moxifloxacin, erythromycin, haloperidol, methadone, ondansetron, dolasetron)
- Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, MAOIs, triptans, fentanyl, tramadol, linezolid, St. John's Wort)
Moderate Interactions
- CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin)
- CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir)
Monitoring
Baseline Monitoring
Rationale: To identify pre-existing electrolyte imbalances that may increase the risk of QT prolongation.
Timing: Prior to administration, especially in patients at risk for QT prolongation.
Rationale: To assess baseline QTc interval, particularly in patients with pre-existing cardiac conditions, electrolyte abnormalities, or those receiving other QT-prolonging drugs.
Timing: Prior to administration, if risk factors for QT prolongation are present.
Routine Monitoring
Frequency: Continuously during and after administration, especially if co-administered with other serotonergic drugs.
Target: Absence of symptoms (e.g., mental status changes, autonomic instability, neuromuscular abnormalities, GI symptoms)
Action Threshold: If symptoms develop, discontinue granisetron and initiate supportive treatment.
Frequency: As needed, post-administration.
Target: Effective control of nausea and vomiting.
Action Threshold: If inadequate control, consider alternative or adjunctive antiemetic therapy.
Symptom Monitoring
- Headache
- Constipation
- Asthenia
- Diarrhea
- Fever
- Dizziness
- Insomnia
- Anxiety
- QT prolongation (palpitations, syncope)
- Serotonin syndrome (agitation, hallucinations, rapid heart rate, fever, sweating, muscle rigidity, twitching, loss of coordination, nausea, vomiting, diarrhea)
Special Patient Groups
Pregnancy
Granisetron is classified as Pregnancy Category B. Animal reproduction studies have shown no evidence of harm to the fetus. There are no adequate and well-controlled studies in pregnant women. Granisetron should be used during pregnancy only if clearly needed.
Trimester-Specific Risks:
Lactation
It is not known whether granisetron is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when granisetron is administered to a nursing woman. The decision to discontinue nursing or discontinue the drug should take into account the importance of the drug to the mother.
Pediatric Use
Granisetron injection is approved for the prevention of nausea and vomiting associated with chemotherapy in pediatric patients 2 years of age and older. Safety and effectiveness in pediatric patients younger than 2 years of age have not been established.
Geriatric Use
No dosage adjustment is recommended based on age alone. However, elderly patients may have reduced renal or hepatic function, which could affect drug clearance. Monitor for adverse effects and consider co-morbidities and concomitant medications.
Clinical Information
Clinical Pearls
- Granisetron is generally well-tolerated with a low incidence of side effects, making it a preferred choice for CINV and PONV.
- Administer IV granisetron slowly (over 5 minutes for CINV, 30 seconds for PONV) to minimize potential for adverse reactions.
- While generally not requiring dose adjustment in renal or hepatic impairment, caution is advised in severe hepatic impairment due to potential for increased plasma concentrations.
- Be mindful of potential for QT prolongation, especially in patients with pre-existing cardiac conditions, electrolyte imbalances, or those on other QT-prolonging medications.
- Educate patients and caregivers about the signs and symptoms of serotonin syndrome, particularly if the patient is on other serotonergic agents.
Alternative Therapies
- Ondansetron (Zofran)
- Palonosetron (Aloxi)
- Dolasetron (Anzemet)
- Netupitant/Palonosetron (Akynzeo)
- Rolapitant (Varubi)
- Aprepitant (Emend)
- Fosaprepitant (Emend IV)
- Dexamethasone
- Prochlorperazine
- Metoclopramide